Macrophages predict treatment outcome in Hodgkin’s lymphoma by Christian Steidl, Pedro Farinha, Randy D. Gascoyne

Get full text

A Comprehensive Updated Review on Magnetic Nanoparticles in Diagnostics by Pedro Farinha, João M. P. Coelho, Catarina Pinto Reis, Maria Manuela Gaspar

Get full text

Vascularization predicts overall survival and risk of transformation in follicular lymphoma by Pedro Farinha, Alastair H. Kyle, Andrew I. Minchinton, Joseph M. Connors, Aly Karsan, Randy D. Gascoyne

Get full text

Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP by Jesse Shustik, Guangming Han, Pedro Farinha, Nathalie A. Johnson, Susana Ben Neriah, Joseph M. Connors, Laurie H. Sehn, Douglas E. Horsman, Randy D. Gascoyne, Christian Steidl

Get full text

Maximum disease diameter is associated with outcomes in stage II follicular lymphoma treated with radiation therapy alone by Yi Xu, Belinda A. Campbell, Matthew Chan, Jessica Chan, Pedro Farinha, Christopher P. Venner, David W. Scott, Alina S. Gerrie, Diego Villa, Laurie H. Sehn, Kerry J. Savage, Andrea C. Lo

Get full text

Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival by Rosalind Ramsey-Goldman, Diane L Kamen, Eva Baecklund, Basile Tessier-Cloutier, David DW Twa, Randy Gascoyne, Nathalie A Johnson, Carin Backlin, Ann E Clarke, Jennifer LF Lee, Pedro Farinha, Sasha Bernatsky

Get full text

P094: Long-term outcomes of bulky classic Hodgkin lymphoma managed with a PET-adapted approach demonstrate excellent outcomes in PET-negative cases by Jowon Laura Kim, Diego Villa, R. Petter Tonseth, Alina S. Gerrie, Don Wilson, Francois Benard, Chris Venner, Brian Skinnider, Pedro Farinha, Graham W. Slack, David W. Scott, Joseph M. Connors, Laurie H. Sehn, Kerry J. Savage

Get full text

Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD by Diego Villa, Laurie H. Sehn, Christina Aquino-Parsons, Petter Tonseth, David W. Scott, Alina S. Gerrie, Donald Wilson, François Bénard, Randy D. Gascoyne, Graham W. Slack, Pedro Farinha, James Morris, Tom Pickles, Joseph M. Connors, Kerry J. Savage

Get full text

The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas by Scott J. Rodig, Jeffery L. Kutok, Jennifer C. Paterson, Hiroaki Nitta, Wenjun Zhang, Bjoern Chapuy, Lynette K. Tumwine, Santiago Montes-Moreno, Claudio Agostinelli, Nathalie A. Johnson, Susana Ben-Neriah, Pedro Farinha, Margaret A. Shipp, Miguel A. Piris, Thomas M. Grogan, Stefano A. Pileri, Randy D. Gascoyne, Teresa Marafioti

Get full text

COO and MYC/BCL2 status do not predict outcome among patients with stage I/II DLBCL: a retrospective multicenter study by Allison Barraclough, Musa Alzahrani, Marianne Schmidt Ettrup, Mark Bishton, Chris van Vliet, Pedro Farinha, Clare Gould, Simone Birch, Laurie H. Sehn, Vishakha Sovani, Mitchell Steven Ward, Bradley Augustson, Jorne Biccler, Joseph M. Connors, David W. Scott, Maher K. Gandhi, Kerry J. Savage, Tarec El-Galaly, Diego Villa, Chan Yoon Cheah

Get full text

Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment by Jie Li, Christopher R. Chin, Hsia-Yuan Ying, Cem Meydan, Matthew R. Teater, Min Xia, Pedro Farinha, Katsuyoshi Takata, Chi-Shuen Chu, Yiyue Jiang, Jenna Eagles, Verena Passerini, Zhanyun Tang, Martin A. Rivas, Oliver Weigert, Trevor J. Pugh, Amy Chadburn, Christian Steidl, David W. Scott, Robert G. Roeder, Christopher E. Mason, Roberta Zappasodi, Wendy Béguelin, Ari M. Melnick

Get full text